XML 36 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Shares to be issued
Paid in Capital
Statutory Reserves
Other Comprehensive (Loss) / Income
Accumulated Deficit
Non controlling Interest
Total
Balance at Dec. 31, 2018 $ 1,030   $ 114,493,283 $ 14,525,712 $ (4,620,930) $ (37,675,202) $ (3,544,624) $ 86,723,893
Balance (in Shares) at Dec. 31, 2018 1,029,528              
Net income (loss)   (8,772,757) (8,772,757)
Purchase of noncontrolling interest   (3,948,242) 3,544,624 (3,948,242)
Issuance of common stock for stock compensation $ 41   148,584 148,625
Issuance of common stock for stock compensation (in Shares) 41,250              
Conversion of convertible notes including accrued interest into common shares $ 185   2,014,791 2,014,976
Conversion of convertible notes including accrued interest into common shares (in Shares) 185,195              
Conversion of long-term notes into common shares $ 176   665,084 665,260
Conversion of long-term notes into common shares (in Shares) 175,400              
Warrants exchanged into shares $ 205   (205)
Warrants exchanged into shares (in Shares) 205,421              
Issuance of common stock for equity financing $ 396   3,309,079 3,309,475
Issuance of common stock for equity financing (in Shares) 395,927              
Foreign currency translation gain (loss)   (1,511,684) (1,511,684)
Balance at Dec. 31, 2019 $ 2,033   116,682,374 14,525,712 (6,132,614) (46,447,959) 78,629,546
Balance (in Shares) at Dec. 31, 2019 2,032,721              
Net income (loss)   (598,551)   (598,551)
Issuance of common stock for stock compensation $ 3   10,996   10,999
Issuance of common stock for stock compensation (in Shares) 3,333              
Conversion of long-term notes into common shares $ 143   533,024   533,167
Conversion of long-term notes into common shares (in Shares) 143,333              
Foreign currency translation gain (loss)   (1,341,276)   (1,341,276)
Balance at Mar. 31, 2020 $ 2,179   117,226,394 14,525,712 (7,473,890) (47,046,510)   77,233,885
Balance (in Shares) at Mar. 31, 2020 2,179,387              
Balance at Dec. 31, 2019 $ 2,033   116,682,374 14,525,712 (6,132,614) (46,447,959) 78,629,546
Balance (in Shares) at Dec. 31, 2019 2,032,721              
Net income (loss)   4,050,824 4,050,824
Issuance of common stock for stock compensation $ 3   10,996 10,999
Issuance of common stock for stock compensation (in Shares) 3,333              
Conversion of long-term notes into common shares $ 867   2,558,716 2,559,583
Conversion of long-term notes into common shares (in Shares) 866,646              
Round-up of fractional shares due to reverse split $ 9   (9)
Round-up of fractional shares due to reverse split (in Shares) 9,100              
Shares to be issued for equity financing $ 265   496,922 497,187
Shares to be issued for equity financing (in Shares) 265,250              
Transfer to Statutory Reserves   629,330 (629,330)
Foreign currency translation gain (loss)   6,406,054 6,406,054
Balance at Dec. 31, 2020 $ 3,177 119,748,999 15,155,042 273,440 (43,026,465) 92,154,193
Balance (in Shares) at Dec. 31, 2020 3,177,050              
Balance at Mar. 31, 2020 $ 2,179   117,226,394 14,525,712 (7,473,890) (47,046,510)   77,233,885
Balance (in Shares) at Mar. 31, 2020 2,179,387              
Net income (loss)   993,940   993,940
Conversion of long-term notes into common shares $ 305   769,444   769,749
Conversion of long-term notes into common shares (in Shares) 304,710              
Round-up of fractional shares due to reverse split $ 9   (9)  
Round-up of fractional shares due to reverse split (in Shares) 9,100              
Transfer to Statutory Reserves   140,494 (140,494)  
Foreign currency translation gain (loss)   58,688   58,688
Balance at Jun. 30, 2020 $ 2,493   117,995,829 14,666,206 (7,415,202) (46,193,064)   79,056,262
Balance (in Shares) at Jun. 30, 2020 2,493,197              
Balance at Dec. 31, 2020 $ 3,177 119,748,999 15,155,042 273,440 (43,026,465) 92,154,193
Balance (in Shares) at Dec. 31, 2020 3,177,050              
Net income (loss) (277,224)   (277,224)
Shares to be issued for equity financing 38,253,041   38,253,041
Transfer to Statutory Reserves 1,538 (1,538)  
Foreign currency translation gain (loss) (1,140,163)   (1,140,163)
Balance at Mar. 31, 2021 $ 3,177 38,253,041 119,748,999 15,156,580 (866,723) (43,305,227)   128,989,847
Balance (in Shares) at Mar. 31, 2021 3,177,050              
Net income (loss)   2,220,571   2,220,571
Conversion of long-term notes into common shares $ 54 502,665   502,719
Conversion of long-term notes into common shares (in Shares) 54,348              
Issuance of common stock for equity financing $ 3,320 (38,253,041) 38,249,721  
Issuance of common stock for equity financing (in Shares) 3,320,000              
Return of shares issued to CEO for equity financing $ (60) (691,260)   (691,320)
Return of shares issued to CEO for equity financing (in Shares) (60,000)              
Transfer to Statutory Reserves 14,774 (14,774)  
Foreign currency translation gain (loss) 2,407,848   2,407,848
Balance at Jun. 30, 2021 $ 6,491 $ 157,810,125 $ 15,171,354 $ 1,541,125 $ (41,099,430)   $ 133,429,665
Balance (in Shares) at Jun. 30, 2021 6,491,398